JPH11501906A - 脊椎骨折のリスクを減少させる方法 - Google Patents

脊椎骨折のリスクを減少させる方法

Info

Publication number
JPH11501906A
JPH11501906A JP8525097A JP52509796A JPH11501906A JP H11501906 A JPH11501906 A JP H11501906A JP 8525097 A JP8525097 A JP 8525097A JP 52509796 A JP52509796 A JP 52509796A JP H11501906 A JPH11501906 A JP H11501906A
Authority
JP
Japan
Prior art keywords
alendronate
years
vertebral
fractures
fracture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8525097A
Other languages
English (en)
Japanese (ja)
Inventor
カーフ，デイビツド・ビー
キヤピツジ，トーマス・ピー
クアン，ヒユイ
サントラ，アーサー・シー，ザ・セカンド
イエイツ，アシユレイ・ジエイ
Original Assignee
メルク エンド カンパニー インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メルク エンド カンパニー インコーポレーテッド filed Critical メルク エンド カンパニー インコーポレーテッド
Publication of JPH11501906A publication Critical patent/JPH11501906A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP8525097A 1995-02-17 1996-02-13 脊椎骨折のリスクを減少させる方法 Pending JPH11501906A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/389,860 US20010051616A1 (en) 1995-02-17 1995-02-17 Method of lessening the risk of vertebral fractures
US389,860 1995-02-17
PCT/US1996/001946 WO1996025166A1 (en) 1995-02-17 1996-02-13 Method of lessening the risk of vertebral fractures

Publications (1)

Publication Number Publication Date
JPH11501906A true JPH11501906A (ja) 1999-02-16

Family

ID=23540050

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8525097A Pending JPH11501906A (ja) 1995-02-17 1996-02-13 脊椎骨折のリスクを減少させる方法

Country Status (14)

Country Link
US (1) US20010051616A1 (xx)
EP (1) EP0809503A4 (xx)
JP (1) JPH11501906A (xx)
KR (1) KR19980702209A (xx)
CN (1) CN1181008A (xx)
AU (1) AU689379B2 (xx)
CA (1) CA2213076A1 (xx)
EA (1) EA000348B1 (xx)
HU (1) HUP9802077A3 (xx)
NZ (1) NZ303476A (xx)
PL (1) PL321836A1 (xx)
SK (1) SK111697A3 (xx)
WO (1) WO1996025166A1 (xx)
ZA (1) ZA961234B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US6416737B1 (en) * 1998-11-19 2002-07-09 Board Of Trustees Of The University Of Arkansas Increasing bone strength with selected bisphosphonates
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
CN100479823C (zh) * 2001-12-21 2009-04-22 宝洁公司 双膦酸盐在制造药物套盒中的用途以及用于增加骨质的套盒
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
WO2003057136A2 (en) * 2001-12-24 2003-07-17 Teva Pharmaceutical Industries Ltd. Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
ES2532393T3 (es) * 2002-05-10 2015-03-26 F. Hoffmann-La Roche Ag Acidos bisfosfónicos para tratamiento y prevención de osteoporosis
NZ536273A (en) 2002-12-20 2007-08-31 Hoffmann La Roche High dose ibandronate formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery

Also Published As

Publication number Publication date
AU4979996A (en) 1996-09-04
HUP9802077A2 (hu) 2000-06-28
EA000348B1 (ru) 1999-04-29
CN1181008A (zh) 1998-05-06
EA199700185A1 (ru) 1997-12-30
US20010051616A1 (en) 2001-12-13
MX9706275A (es) 1997-11-29
PL321836A1 (en) 1997-12-22
NZ303476A (en) 2000-07-28
KR19980702209A (ko) 1998-07-15
ZA961234B (en) 1996-08-27
HUP9802077A3 (en) 2001-10-29
WO1996025166A1 (en) 1996-08-22
EP0809503A4 (en) 2001-12-05
EP0809503A1 (en) 1997-12-03
SK111697A3 (en) 1998-02-04
CA2213076A1 (en) 1996-08-22
AU689379B2 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
Sharpe et al. Alendronate: an update of its use in osteoporosis
JP6301524B2 (ja) 骨粗鬆症治療剤ないし予防剤
EA000964B1 (ru) Способ лечения или предупреждения остеопороза
AU690431B2 (en) Method of lessening the risk of non-vertebral bone fractures
Trevisan et al. Bone loss and recovery in regional migratory osteoporosis
JPH11501906A (ja) 脊椎骨折のリスクを減少させる方法
TW200412979A (en) Method for preventing or reducing secondary fractures after hip fracture
JPH11506750A (ja) 慢性関節リウマチに係わる骨欠損に対するビスホスホネート療法
JPH10506648A (ja) 骨粗鬆症予防へのアレンドロネートの使用
JPH10506638A (ja) アレンドロネート又はその塩の投与による歯喪失の予防
TW453880B (en) Pharmaceutical compositions of alendronate for reducing the risk and severity of vertebral or non-vertebral fractures, decreasing spinal deformity and preventing loss of height
TW201105333A (en) Agent for preventing non-traumatic vertebral fracture in severe osteoporosis patients which comprises eldecalcitol
TW201105332A (en) Agent for preventing forearm bone fracture which comprises eldecalcitol
MXPA97006275A (en) The use of alendronate to prepare compositions to reduce the risk of vertebra fractures
MXPA97009906A (en) Use of bisphosphonates to prepare compositions to prevent loss of associated bone conterapia immunosupres